AU6117998A - 3-oxadiazolylquinoxaline derivatives - Google Patents

3-oxadiazolylquinoxaline derivatives

Info

Publication number
AU6117998A
AU6117998A AU61179/98A AU6117998A AU6117998A AU 6117998 A AU6117998 A AU 6117998A AU 61179/98 A AU61179/98 A AU 61179/98A AU 6117998 A AU6117998 A AU 6117998A AU 6117998 A AU6117998 A AU 6117998A
Authority
AU
Australia
Prior art keywords
oxadiazolylquinoxaline
derivatives
oxadiazolylquinoxaline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU61179/98A
Inventor
Kiyoshi Furukawa
Osamu Odai
Kazunori Ohno
Makoto Oka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of AU6117998A publication Critical patent/AU6117998A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
AU61179/98A 1997-03-21 1998-02-27 3-oxadiazolylquinoxaline derivatives Withdrawn AU6117998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9-87646 1997-03-21
JP08764697A JP2002241379A (en) 1997-03-21 1997-03-21 3-oxadiazolylquinoxaline derivative
PCT/JP1998/000827 WO1998042701A1 (en) 1997-03-21 1998-02-27 3-oxadiazolylquinoxaline derivatives

Publications (1)

Publication Number Publication Date
AU6117998A true AU6117998A (en) 1998-10-20

Family

ID=13920749

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61179/98A Withdrawn AU6117998A (en) 1997-03-21 1998-02-27 3-oxadiazolylquinoxaline derivatives

Country Status (3)

Country Link
JP (1) JP2002241379A (en)
AU (1) AU6117998A (en)
WO (1) WO1998042701A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW486479B (en) * 1997-07-15 2002-05-11 Dainippon Pharmaceutical Co 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives
KR100684843B1 (en) * 2005-06-08 2007-02-20 삼성에스디아이 주식회사 Multi-plasma display panel
CN102264721B (en) 2008-11-10 2015-12-09 沃泰克斯药物股份有限公司 As the compound of ATR kinase inhibitor
RS56995B1 (en) 2008-12-19 2018-05-31 Vertex Pharma Pyrazine derivatives useful as inhibitors of atr kinase
WO2011143419A1 (en) 2010-05-12 2011-11-17 Vertex Pharmaceuticals Incorporated Pyrazines useful as inhibitors of atr kinase
WO2011143423A2 (en) 2010-05-12 2011-11-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
SG185524A1 (en) 2010-05-12 2012-12-28 Vertex Pharma Compounds useful as inhibitors of atr kinase
CN102947272A (en) 2010-05-12 2013-02-27 沃泰克斯药物股份有限公司 2 -aminopyridine derivatives useful as inhibitors of atr kinase
US9334244B2 (en) 2010-05-12 2016-05-10 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8969356B2 (en) 2010-05-12 2015-03-03 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
MX2013000103A (en) 2010-06-23 2013-06-13 Vertex Pharma Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase.
EP2694498B1 (en) 2011-04-05 2016-03-30 Vertex Pharmaceuticals Incorporated Aminopyrazine compounds useful as inhibitors of tra kinase
WO2012178124A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2012178123A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2723746A1 (en) 2011-06-22 2014-04-30 Vertex Pharmaceuticals Inc. Compounds useful as inhibitors of atr kinase
CN108464983A (en) 2011-09-30 2018-08-31 沃泰克斯药物股份有限公司 With ATR inhibitor for treating cancer of pancreas and non-small cell lung cancer
WO2013049719A1 (en) 2011-09-30 2013-04-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
PT2940017T (en) 2011-09-30 2019-10-31 Vertex Pharma Process for making compounds useful as inhibitors of atr kinase
US8853217B2 (en) 2011-09-30 2014-10-07 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2013049722A1 (en) 2011-09-30 2013-04-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US8841450B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8846918B2 (en) 2011-11-09 2014-09-30 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8841337B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2013071088A1 (en) 2011-11-09 2013-05-16 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2776419B1 (en) 2011-11-09 2016-05-11 Vertex Pharmaceuticals Incorporated Pyrazine compounds useful as inhibitors of atr kinase
NZ700580A (en) 2012-04-05 2016-07-29 Vertex Pharma Compounds useful as inhibitors of atr kinase and combination therapies thereof
DK2904406T3 (en) 2012-10-04 2018-06-18 Vertex Pharma METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
WO2014062604A1 (en) 2012-10-16 2014-04-24 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US9340546B2 (en) 2012-12-07 2016-05-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2014143240A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
HUE046727T2 (en) 2013-12-06 2020-03-30 Vertex Pharma 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
AU2015271030B2 (en) 2014-06-05 2019-05-16 Vertex Pharmaceuticals Incorporated Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo [1,5-a] pyrimidin-3-carboxamide compound useful as ATR kinase inhibitor, the preparation of said compound and different solid forms thereof
PL3157566T3 (en) 2014-06-17 2019-10-31 Vertex Pharma Method for treating cancer using a combination of chk1 and atr inhibitors
JP7187308B2 (en) 2015-09-30 2022-12-12 バーテックス ファーマシューティカルズ インコーポレイテッド Methods for treating cancer using combinations of DNA damaging agents and ATR inhibitors
CN114539169A (en) * 2020-11-18 2022-05-27 江苏恒盛药业有限公司 Method for synthesizing pyrazine ring containing substituent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA936048B (en) * 1992-09-02 1994-03-15 Dainippon Pharmaceutical Co Novel 3-oxadiazolyl-1,6-napthyridine derivatives

Also Published As

Publication number Publication date
JP2002241379A (en) 2002-08-28
WO1998042701A1 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU1709299A (en) Mixer-injectors
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU1027499A (en) 32P-polyphosphazene
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU5272198A (en) EMP-charge-eliminator
AU7813598A (en) Betulinol derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU4117497A (en) Micropolarimeter
AU1174199A (en) Biphenylamidine derivatives
AU6729498A (en) Thiazolimine derivatives
AUPO863197A0 (en) Novel derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU6185898A (en) Clavaspirins
AU3685097A (en) N-benzylazolium derivatives
AU6115798A (en) Saponarin derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU1691399A (en) 5-arylpyrrole derivatives
AU7873198A (en) Polysaccharide-peptide derivatives
AU2123797A (en) 2-thioxotetrahydropyrimidin-4-one derivatives